CBLI Income Statement

Click line-items for a historical chart and %
REVENUES
Grant and contract
Sales Revenue, Net, Total
OPERATING EXPENSES
Research and development 5.33M
General and administrative 3.48M
Total operating expenses 8.81M
LOSS FROM OPERATIONS -7.45M
OTHER (INCOME)/EXPENSE
Interest income 79.96K
Other income
Other expense
Change in value of warrant liability
Total other (income)/expense -3.34M
NET INCOME/(LOSS) -10.79M
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 1.02M
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC. -9.76M
NET INCOME/(LOSS) AVAILABLE TO COMMON SHAREHOLDERS PER SHARE OF COMMON STOCK BASIC (in dollars per share)
NET INCOME/(LOSS) AVAILABLE TO COMMON SHAREHOLDERS PER SHARE OF COMMON STOCK DILUTED (in dollars per share)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATING NET INCOME/(LOSS) PER SHARE, BASIC (in shares)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATING NET INCOME/(LOSS) PER SHARE, DILUTED (in shares)

Entities mentioned with CBLI

View All Entities